Cargando…
Islet Amyloid Polypeptide Is a Target Antigen for Diabetogenic CD4(+) T Cells
OBJECTIVE: To investigate autoantigens in β-cells, we have used a panel of pathogenic T-cell clones that were derived from the NOD mouse. Our particular focus in this study was on the identification of the target antigen for the highly diabetogenic T-cell clone BDC-5.2.9. RESEARCH DESIGN AND METHODS...
Autores principales: | Delong, Thomas, Baker, Rocky L., Reisdorph, Nichole, Reisdorph, Richard, Powell, Roger L., Armstrong, Michael, Barbour, Gene, Bradley, Brenda, Haskins, Kathryn |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Diabetes Association
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3161333/ https://www.ncbi.nlm.nih.gov/pubmed/21734016 http://dx.doi.org/10.2337/db11-0288 |
Ejemplares similares
-
Diabetogenic T-Cell Clones Recognize an Altered Peptide of Chromogranin A
por: Delong, Thomas, et al.
Publicado: (2012) -
Slc11a1 Enhances the Autoimmune Diabetogenic T-Cell Response by Altering Processing and Presentation of Pancreatic Islet Antigens
por: Dai, Yang D., et al.
Publicado: (2009) -
In Vivo Enrichment of Diabetogenic T Cells
por: Thelin, Martin A., et al.
Publicado: (2017) -
Hybrid Insulin Peptides Are Autoantigens in Type 1 Diabetes
por: Baker, Rocky L., et al.
Publicado: (2019) -
Hybrid Insulin Peptides Are Recognized by Human T Cells in the Context of DRB1*04:01
por: Arribas-Layton, David, et al.
Publicado: (2020)